Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology · 2014
[Meta analysis of the changes of regulatory T cell number in patients with active systemic lupus erythematosus].
Аннотация на английскомСтатьяМетаанализПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xiang Yonggang, Xia Lingyun, Zeng Xiantao, Zhang Yong, Liu Shengwu
Аннотация
OBJECTIVE: To evaluate the change of regulatory T cells (Tregs) in patients with active systemic lupus erythematosus (SLE) using meta-analysis.
METHODS: The PubMed and China Biomedical Literature (CBM) databases were searched for relevant studies up to August 31, 2013. After quality assessment and data extraction for included studies, a meta-analysis was performed using the software of Comprehensive-Meta Analysis (CMA) v2.2.
RESULTS: Finally 22 case-control studies were recruited, including 12 studies reporting the change of Treg number and 12 studies for the change of Treg:CD4(+)T cell ratio. The quality of studies was moderate to high. It demonstrated that the Treg number in peripheral blood mononuclear cells (PBMCs) of active SLE patients significantly decreased than ones in controls (WMD=-1.23%, %CI=-1.87% to -0.59%). Then, subgroup analysis was performed based on the different surface markers of Tregs. It showed that the Treg number in PBMCs of active SLE patients decreased by 1.56% for the CD4(+)CD25(+) Tregs (WMD=-1.56%, 95% CI=-2.18% to -0.94%), and by 0.91% for the CD4(+)CD25(high) Tregs (WMD=-0.91%, 95% CI=-1.52% to -0.29%) compared with ones in controls. As for the ratio of Tregs to CD4(+) T cells, there was no significant difference between the SLE patients and the controls. Sensitivity analysis showed the results were robust, and the Funnel Plots showed there was no publication bias.
CONCLUSION: Based on the current evidences, the development of SLE may be due to the decrease of Treg number in PBMCs, not to the abnormal ratio of Tregs to CD4(+) T cells.
METHODS: The PubMed and China Biomedical Literature (CBM) databases were searched for relevant studies up to August 31, 2013. After quality assessment and data extraction for included studies, a meta-analysis was performed using the software of Comprehensive-Meta Analysis (CMA) v2.2.
RESULTS: Finally 22 case-control studies were recruited, including 12 studies reporting the change of Treg number and 12 studies for the change of Treg:CD4(+)T cell ratio. The quality of studies was moderate to high. It demonstrated that the Treg number in peripheral blood mononuclear cells (PBMCs) of active SLE patients significantly decreased than ones in controls (WMD=-1.23%, %CI=-1.87% to -0.59%). Then, subgroup analysis was performed based on the different surface markers of Tregs. It showed that the Treg number in PBMCs of active SLE patients decreased by 1.56% for the CD4(+)CD25(+) Tregs (WMD=-1.56%, 95% CI=-2.18% to -0.94%), and by 0.91% for the CD4(+)CD25(high) Tregs (WMD=-0.91%, 95% CI=-1.52% to -0.29%) compared with ones in controls. As for the ratio of Tregs to CD4(+) T cells, there was no significant difference between the SLE patients and the controls. Sensitivity analysis showed the results were robust, and the Funnel Plots showed there was no publication bias.
CONCLUSION: Based on the current evidences, the development of SLE may be due to the decrease of Treg number in PBMCs, not to the abnormal ratio of Tregs to CD4(+) T cells.